Alteration of CD44 expression in HIV type 1-infected T cell lines

AIDS Research and Human Retroviruses

Volumn 12, Issue 17, 1996, Pages 1615-1622

  Giordanengo, Valérie ^a   Limouse, Martine ^a   Doglio, Alain ^a   Lesimple, Josette ^a   Lefebvre, Jean Claude ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE HOMING; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0030459707     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1615     Document Type: Article

References (50)

1. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, and Fauci AS: Qualitative loss of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
2. + T helper depletion occurs. J Clin Invest 1988;82:1908-1914.
3. Terpstra FG, Al BJM, Ross MTL, De Wolf F, Goudsmit J, and Miedema F: Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: Rapid and persistent loss of B cell function after HIV infection. Eur J Immunol 1989;19:667-673.
4. Harper ME, Marselle LM, Gallo RC, and Wong-Staal F: Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 1986;83:772-776.
5. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinical latent stage of disease. Nature (London) 1993;362:355.
6. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
7. Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Dauguet C, Vilmer E, Griscelli C, Brun-Vézinet F, Rouzioux C, Gluckman JC, Chermann JC, and Montagnier L: Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984;225:59-63.
8. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
9. Hoxie JA, Alpers JD, Rackowski JL, Huebner K, Haggarty BS, Cedarbaum AJ, and Reed JC: Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 1986;234: 1123-1127.
10. Cucchiarini M, Cagnon L, Giordanengo V, Doglio A, and Lefebvre JC: Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins. J AIDS 1995;8:427-436.
11. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis T, Iniotaki-Theodoraki A, and Kosmidis J: Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J AIDS 1994;7:245-253.
12. Oravecz T, Roderiquez G, Koffi J, Wang J, Ditto M, Bou-Habib DC, Lusso P, and Norcross MA: CD26 expression correlates with entry, replication and cytopathicity of monocytotrophic HIV-1 strains in a T-cell line. Nat Med 1995;1:919-926.
13. y antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). J Exp Med 1988;67:323-331.
14. Lefebvre JC, Giordanengo V, Doglio A, Cagnon L, Breittmayer JP, Peyron JF, and Lesimple J: Altered sialylation of CD45 in HIV-1-infected T lymphocytes. Virology 1994;199:265-274.
15. Lefebvre JC, Giordanengo V, Limouse M, Doglio A, Cucchiarini M, Monpoux F, Mariani R, and Peyron JF: Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J Exp Med 1994;180:1609-1617.
16. Lee-Guo MM and Hildreth JEK: HIV-induced loss of CD44 expression in monocytic cell lines. J Immunol 1993;151:2225-2236.
17. Jackson DG, Buckley J, and Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992;267:4732-4739.
18. Stamenkovic I, Aruffo A, Amiot M, and Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10:343-348.
19. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, and Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
20. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 1992;103: 293-298.
21. Koopman G, Van Kooyk Y, de Graaff M, Meyer CJLM, Figdor CG, and Pals ST: Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 1990;145:3589-3593.
22. Jalkanen S, Bargatze RF, Herron LR, and Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986;16:1195-1202.
23. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, and Butcher EC: Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988;141:1615-1623.
24. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, and Bernard A: CD44 contributes to T cell activation. J Immunol 1989;143:798-801.
25. Denning SM, Le PT, Singer KH, and Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 1990;144:7-15.
26. Pierres A, Lipcey C, Mawas C, and Olive D: A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 1992;22:413-117.
27. Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, and Aune TM: Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 1991;147:2493-2499.
28. Schimizu Y, van Seventer GA, Siraganian R, Wahl L, and Shaw S: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 1989;143:2457-2463.
29. Budd RC, Cerottini JC, Horvath C, Bron C, Pedrazzini T, Howe RC, and MacDonald HR: Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 1987;138:3120-3129.
30. Budd RC, Cerottini JC, and MacDonald HR: Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells. J Immunol 1987;138:1009-1013.
31. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, and Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-12164.
32. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, and Zöller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-685.
33. Herrlich P, Zöller M, Pals ST, and Ponta H: CD44 splice variants: Metastases meet lymphocytes. Immunol Today 1993;14:395-398.
34. Bartolazzi A, Peach R, Aruffo A, and Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994;180:53-66.
35. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, and Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994;124:71-82.
36. Dukes CS, Yu Y, Rivadeneira ED, Sauls DL, Liao HX, Haynes BF, and Weinberg JB: Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism. J Virol 1995;69:4000-4005.
37. Rivadeneira ED, Sauls DL, Yu Y, Haynes BF, and Weinberg JB: Inhibition of HIV type 1 infection of mononuclear phagocytes by anti-CD44 antibodies. Aids Res Hum Retroviruses 1995;11:541-546.
38. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
39. + individuals. Blood 1995;86:2302-23I1.
40. Davis GL, Dibner MD, and Battey JF: Guanidine isothiocyanate preparation of total RNA. In: Basic Methods in Molecular Biology (Davis LG, Ed.). Elsevier, New York, 1986, pp. 130-135.
41. Fujiwara T, Oda K, Yokota S, Takatsuki A, and Ikehara Y: Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem 1988;263:18545-18552.
42. Imai Y, Lasky LA, and Rosen SD: Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature (London) 1993;361:555-557.
43. Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muinos FX, Fresno M, and Sanchez-Madrid F: Down-regulation by tumor necrosis factor-α of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol 1991;21:3045-3048.
44. Bazil V and Horejsi V: Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J Immunol 1992;149:747-753.
45. Bazil V and Strominger JL: Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. J Immunol 1994;152:1314-1322.
46. Stamenkovic I, Amiot M, Pesando JM, and Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-1062.
47. + lymphocytes. Proc Natl Acad Sci USA 1989;86:3301-3305.
48. + lymphocytes that includes memory cells. J Immunol 1990;144:3779-3783.
49. Kryworuckho M, Diaz-Mitoma F, and Kumar A: CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Immunology 1995;86:41-48.
50. Rubin H: A virus in chick embryos which induces resistance in vitro to infection with Rous sarcoma virus. Proc Natl Acad Sci USA 1960;46:1105-1119.